These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34961893)

  • 21. Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.
    Scarioni M; Gami-Patel P; Peeters CFW; de Koning F; Seelaar H; Mol MO; van Swieten JC; ; Rozemuller AJM; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
    Brain; 2023 Jan; 146(1):307-320. PubMed ID: 35136978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?
    Mol MO; Miedema SSM; van Swieten JC; van Rooij JGJ; Dopper EGP
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology.
    Burke SE; Phillips JS; Olm CA; Peterson CS; Cook PA; Gee JC; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M
    Neurobiol Aging; 2022 May; 113():95-107. PubMed ID: 35325815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
    Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice.
    Walker AK; Tripathy K; Restrepo CR; Ge G; Xu Y; Kwong LK; Trojanowski JQ; Lee VM
    Hum Mol Genet; 2015 Dec; 24(25):7241-54. PubMed ID: 26476406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
    Mann DMA; Snowden JS
    Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
    A Armstrong R
    Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortical and subcortical pathological burden and neuronal loss in an autopsy series of FTLD-TDP-type C.
    Kawles A; Nishihira Y; Feldman A; Gill N; Minogue G; Keszycki R; Coventry C; Spencer C; Lilek J; Ajroud K; Coppola G; Rademakers R; Rogalski E; Weintraub S; Zhang H; Flanagan ME; Bigio EH; Mesulam MM; Geula C; Mao Q; Gefen T
    Brain; 2022 Apr; 145(3):1069-1078. PubMed ID: 34919645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
    Whitwell JL; Jack CR; Parisi JE; Senjem ML; Knopman DS; Boeve BF; Rademakers R; Baker M; Petersen RC; Dickson DW; Josephs KA
    Neurology; 2010 Dec; 75(24):2212-20. PubMed ID: 21172844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology.
    Koga S; Zhou X; Murakami A; Fernandez De Castro C; Baker MC; Rademakers R; Dickson DW
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12778. PubMed ID: 34823271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laminar distribution of the pathological changes in sporadic frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy: a quantitative study using polynomial curve fitting.
    Armstrong RA; Hamilton RL; Mackenzie IR; Hedreen J; Cairns NJ
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):335-47. PubMed ID: 22804696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal VCP loss of function recapitulates FTLD-TDP pathology.
    Wani A; Zhu J; Ulrich JD; Eteleeb A; Sauerbeck AD; Reitz SJ; Arhzaouy K; Ikenaga C; Yuede CM; Pittman SK; Wang F; Li S; Benitez BA; Cruchaga C; Kummer TT; Harari O; Chou TF; Schröder R; Clemen CS; Weihl CC
    Cell Rep; 2021 Jul; 36(3):109399. PubMed ID: 34289347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
    Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
    Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signature laminar distributions of pathology in frontotemporal lobar degeneration.
    Ohm DT; Cousins KAQ; Xie SX; Peterson C; McMillan CT; Massimo L; Raskovsky K; Wolk DA; Van Deerlin VM; Elman L; Spindler M; Deik A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol; 2022 Mar; 143(3):363-382. PubMed ID: 34997851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
    Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
    Seelaar H; Klijnsma KY; de Koning I; van der Lugt A; Chiu WZ; Azmani A; Rozemuller AJ; van Swieten JC
    J Neurol; 2010 May; 257(5):747-53. PubMed ID: 19946779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA; Carter D; Cairns NJ
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of Microglial Cell Activation in Alzheimer Disease and Frontotemporal Lobar Degeneration.
    Taipa R; Brochado P; Robinson A; Reis I; Costa P; Mann DM; Melo Pires M; Sousa N
    Neurodegener Dis; 2017; 17(4-5):145-154. PubMed ID: 28445885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.
    Hortobágyi T; Troakes C; Nishimura AL; Vance C; van Swieten JC; Seelaar H; King A; Al-Sarraj S; Rogelj B; Shaw CE
    Acta Neuropathol; 2011 Apr; 121(4):519-27. PubMed ID: 21360076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.